» Articles » PMID: 17994794

Cryoablation Induces Necrosis and Apoptosis in Lung Adenocarcinoma in Mice

Overview
Date 2007 Nov 13
PMID 17994794
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

This study evaluated cryoablation on subcutaneously transplanted tumors of lung adenocarcinoma LA795 in T739 mice in vivo, in an effort to assess the feasibility of cryoablation in treatment of NSCLC. Subcutaneously transplanted lung adenocarcinoma LA795 was implanted into T739 mice yielding tumors of approximately 2.5 cm in diameter. Following cryoablation, the various modes of cell death were studied: necrosis in the central frozen zone by light microscopy and apoptosis in periphery of the frozen zone by in situ end labeling (TUNEL). Bc1-2 and bax expression were detected by immunohistochemical SABC procedures, and the cleavage and activation of Caspase 3 and PARP in peripheral zone by Western blot. We find that in central cryoablated zone, necrosis was the dominant mode of cell death occurring at three hours and four days post-thaw. The first three-hour necrosis peak involved approximately 47% of the tumor while the four-day peak increased in volume to 68% of the tumor. In peripheral cryoablation zone, definite cell apoptosis could be observed by morphological examination under light microscope and TUNEL staining, peaking at 8-16 h after cryoablation. Immunohistochemical results yielded little change in bcl-2 protein expression before and after cryoablation. However, bax protein expression was up-regulated significantly after cryoablation. In addition, cleavage and activation of Caspase-3 and PARP occurred in the peripheral freeze zone after the treatment. It indicated that Cryoablation efficiently induces cell death both by necrosis and apoptosis. Cryoablation appears to induce apoptosis in the peripheral freeze zone through the intrinsic mitochondrial caspase pathway based on bax upregulation. This observation allows us to suggest that cryoablation may be combined with chemotherapy to increase cancer destruction.

Citing Articles

Early Effects of Bronchoscopic Cryotherapy in Metastatic Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Single-Center Prospective Study.

Vasiliauskas G, Zemaite E, Skrodeniene E, Poskiene L, Maziliauskiene G, Macionis A Diagnostics (Basel). 2025; 15(2.

PMID: 39857085 PMC: 11763732. DOI: 10.3390/diagnostics15020201.


Progress in the cryoablation and cryoimmunotherapy for tumor.

Chen Z, Meng L, Zhang J, Zhang X Front Immunol. 2023; 14:1094009.

PMID: 36761748 PMC: 9907027. DOI: 10.3389/fimmu.2023.1094009.


Boosting the Immune Response-Combining Local and Immune Therapy for Prostate Cancer Treatment.

Karwacki J, Kielbik A, Szlasa W, Sauer N, Kowalczyk K, Krajewski W Cells. 2022; 11(18).

PMID: 36139368 PMC: 9496996. DOI: 10.3390/cells11182793.


Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.

Hoover A, Liu K, DeVette C, Krawic J, Medcalf A, West C Clin Transl Med. 2022; 12(7):e937.

PMID: 35808806 PMC: 9270578. DOI: 10.1002/ctm2.937.


CIRSE Standards of Practice on Thermal Ablation of Bone Tumours.

Ryan A, Byrne C, Pusceddu C, Buy X, Tsoumakidou G, Filippiadis D Cardiovasc Intervent Radiol. 2022; 45(5):591-605.

PMID: 35348870 PMC: 9018647. DOI: 10.1007/s00270-022-03126-x.